CSF-Targeted Proteomics Indicate Amyloid-Beta Ratios in Patients with Alzheimer’s Dementia Spectrum
Background. According to recent studies, amyloid-β (Aβ) isoforms as cerebrospinal fluid (CSF) biomarkers have remarkable predictive value for cognitive decline in the early stages of Alzheimer’s disease (AD). Herein, we aimed to investigate the correlations between several targeted proteomics in CSF...
Main Authors: | Maryam Behzad, Negin Zirak, Ghazal Hamidi Madani, Linda Baidoo, Ali Rezaei, Shima Karbasi, Mohammad Sadeghi, Mahan Shafie, Mahsa Mayeli, null Alzheimer’s Disease Neuroimaging Initiative |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2023-01-01
|
Series: | International Journal of Alzheimer's Disease |
Online Access: | http://dx.doi.org/10.1155/2023/5336273 |
Similar Items
-
Sex-dependent association of serum uric acid levels with amyloid accumulation among amyloid-positive older adults.
by: Guanan Zhao, et al.
Published: (2024-01-01) -
CSF TNF α levels were associated with conversion from mild cognitive impairment to dementia.
by: Pan Fu, et al.
Published: (2022-01-01) -
A Comprehensive Investigation of the Potential Role of Lipoproteins and Metabolite Profile as Biomarkers of Alzheimer’s Disease Compared to the Known CSF Biomarkers
by: Azam Sajjadi Nasab, et al.
Published: (2023-01-01) -
Impact of amyloid and tau positivity on longitudinal brain atrophy in cognitively normal individuals
by: Motonobu Fujishima, et al.
Published: (2024-04-01) -
Machine learning prediction of future amyloid beta positivity in amyloid-negative individuals
by: Elaheh Moradi, et al.
Published: (2024-02-01)